Victor Moyo
Hoofd Techniek/Wetenschap/O&O bij TRAWS PHARMA, INC.
Actieve functies van Victor Moyo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TRAWS PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 24-10-2023 | - |
OncoPep, Inc.
 OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Corporate Officer/Principal | 01-05-2022 | - |
Loopbaan van Victor Moyo
Opleiding van Victor Moyo
| University of Zimbabwe | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Zimbabwe | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Finance |
- Beurs
- Insiders
- Victor Moyo
- Ervaring
